Page 25 - Diamicron MR MIG Cycle 2(20-21) Final

CPRD Jacket Folder

Target - All Doctors

February

Objective
To highlight the superiority of Diamicron MR over Sitagliptin in in reducing HbA1c, with similar
durability and persistence and low rates of hypoglycemic events, in individuals with type 2
diabetes on metformin treatment and HbA1c above the target of 7.0%.

Content

CPRD scientific full paper

Format
A4 size Jacket Folder